AGA Backs Fecal Microbiota-Based Therapies for Recurrent C. Diff

But new guidelines do not recommend use in inflammatory bowel disease or irritable bowel syndrome

Related Keywords

United States ,Boston ,Massachusetts ,American ,Katherine Kahn ,Anne Peery ,Colleen Kelly ,Harvard Medical School ,American Gastroenterological Association ,University Of North Carolina At Chapel Hill ,North Carolina ,Chapel Hill ,Medpage Today ,Gastroenterological Association ,Irritable Bowel ,Irritable Bowel Syndrome ,Inflammatory Bowel Disease ,Recurrent ,Megacolon ,